Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarnow

Showing results (811-820 of 848) with videos related to

Pageof 85
Sort By:
Free Radical Biology & Medicine|November 25, 2021
Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trialEmil List Larsen, Laura K Kjær, Louise Lundby-Christensen, et al.
Iscience|August 16, 2024
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approachLeonie M Weskamm, Paulina Tarnow, Charlotte Harms, et al.
Journal of Diabetes Science and Technology|September 6, 2023
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.
Calcified Tissue International|May 30, 2020
Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes MellitusAzra Karahasanovic Nordklint, Thomas Peter Almdal, Peter Vestergaard, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 21, 2018
The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trialA K Nordklint, T P Almdal, P Vestergaard, et al.
Diabetes Technology & Therapeutics|April 25, 2022
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.
Diabetes, Obesity & Metabolism|February 7, 2023
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Peter Lommer Kristensen, et al.
Diabetologia|December 6, 2014
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetesMarine Germain, Marcus G Pezzolesi, Niina Sandholm, et al.
Diabetes, Obesity & Metabolism|October 13, 2021
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trialUlrik Pedersen-Bjergaard, Rikke M Agesen, Julie M B Brøsen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 27, 2016
Clinicians in 25 countries prefer to use lower levels of oxygen to resuscitate preterm infants at birthJu Lee Oei, Alpana Ghadge, Elisabeth Coates, et al.
Pageof 85

Showing results (811-820 of 848) with videos related to

Sort By:
Pageof 85
Free Radical Biology & Medicine|November 25, 2021
Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trialEmil List Larsen, Laura K Kjær, Louise Lundby-Christensen, et al.
Iscience|August 16, 2024
Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approachLeonie M Weskamm, Paulina Tarnow, Charlotte Harms, et al.
Journal of Diabetes Science and Technology|September 6, 2023
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.
Calcified Tissue International|May 30, 2020
Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes MellitusAzra Karahasanovic Nordklint, Thomas Peter Almdal, Peter Vestergaard, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 21, 2018
The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trialA K Nordklint, T P Almdal, P Vestergaard, et al.
Diabetes Technology & Therapeutics|April 25, 2022
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.
Diabetes, Obesity & Metabolism|February 7, 2023
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Peter Lommer Kristensen, et al.
Diabetologia|December 6, 2014
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetesMarine Germain, Marcus G Pezzolesi, Niina Sandholm, et al.
Diabetes, Obesity & Metabolism|October 13, 2021
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trialUlrik Pedersen-Bjergaard, Rikke M Agesen, Julie M B Brøsen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 27, 2016
Clinicians in 25 countries prefer to use lower levels of oxygen to resuscitate preterm infants at birthJu Lee Oei, Alpana Ghadge, Elisabeth Coates, et al.
Pageof 85